Cargando…

Rhythm monitoring, success definition, recurrence, and anticoagulation after atrial fibrillation ablation: results from an EHRA survey

Atrial fibrillation (AF) is a major challenge for the healthcare field. Pulmonary vein isolation is the most effective treatment for the maintenance of sinus rhythm. However, clinical endpoints for the procedure vary significantly among studies. There is no consensus on the definition of recurrence...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwab, Ana Carolina, Anic, Ante, Farkowski, Michal M, Guerra, Jose, Iliodromitis, Konstantinos E, Jubele, Kristine, Providencia, Rui, Chun, Julian K R, Boveda, Serge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934999/
https://www.ncbi.nlm.nih.gov/pubmed/36372986
http://dx.doi.org/10.1093/europace/euac194
_version_ 1784889988355194880
author Schwab, Ana Carolina
Anic, Ante
Farkowski, Michal M
Guerra, Jose
Iliodromitis, Konstantinos E
Jubele, Kristine
Providencia, Rui
Chun, Julian K R
Boveda, Serge
author_facet Schwab, Ana Carolina
Anic, Ante
Farkowski, Michal M
Guerra, Jose
Iliodromitis, Konstantinos E
Jubele, Kristine
Providencia, Rui
Chun, Julian K R
Boveda, Serge
author_sort Schwab, Ana Carolina
collection PubMed
description Atrial fibrillation (AF) is a major challenge for the healthcare field. Pulmonary vein isolation is the most effective treatment for the maintenance of sinus rhythm. However, clinical endpoints for the procedure vary significantly among studies. There is no consensus on the definition of recurrence and no clear roadmap on how to deal with recurrences after a failed ablation. The purpose of this study was to perform a survey in order to show how clinicians currently approach this knowledge gap. An online survey, supported by the European Heart Rhythm Association (EHRA) Scientific Initiatives Committee, was conducted between 1 April 2022 and 8 May 2022. An anonymous questionnaire was disseminated via social media and EHRA newsletters, for clinicians to complete. This consisted of 18 multiple-choice questions regarding rhythm monitoring, definitions of a successful ablation, clinical practices after a failed AF ablation, and the continuance of anticoagulation. A total of 107 replies were collected across Europe. Most respondents (82%) perform routine monitoring for AF recurrences after ablation, with 51% of them preferring a long-term monitoring strategy. Cost was reported to have an impact on the choice of monitoring strategy. Self-screening was recommended by most (71%) of the respondents. The combination of absence of symptoms and recorded AF was the definition of success for most (83%) of the respondents. Cessation of anticoagulation after ablation was an option mostly for patients with paroxysmal AF and a low CHA(2)DS(2)-VASc score. The majority of physicians perform routine monitoring after AF ablation. For most physicians, the combination of the absence of symptoms and electrocardiographic endpoints defines a successful result after AF ablation.
format Online
Article
Text
id pubmed-9934999
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-99349992023-02-17 Rhythm monitoring, success definition, recurrence, and anticoagulation after atrial fibrillation ablation: results from an EHRA survey Schwab, Ana Carolina Anic, Ante Farkowski, Michal M Guerra, Jose Iliodromitis, Konstantinos E Jubele, Kristine Providencia, Rui Chun, Julian K R Boveda, Serge Europace EHRA Survey Atrial fibrillation (AF) is a major challenge for the healthcare field. Pulmonary vein isolation is the most effective treatment for the maintenance of sinus rhythm. However, clinical endpoints for the procedure vary significantly among studies. There is no consensus on the definition of recurrence and no clear roadmap on how to deal with recurrences after a failed ablation. The purpose of this study was to perform a survey in order to show how clinicians currently approach this knowledge gap. An online survey, supported by the European Heart Rhythm Association (EHRA) Scientific Initiatives Committee, was conducted between 1 April 2022 and 8 May 2022. An anonymous questionnaire was disseminated via social media and EHRA newsletters, for clinicians to complete. This consisted of 18 multiple-choice questions regarding rhythm monitoring, definitions of a successful ablation, clinical practices after a failed AF ablation, and the continuance of anticoagulation. A total of 107 replies were collected across Europe. Most respondents (82%) perform routine monitoring for AF recurrences after ablation, with 51% of them preferring a long-term monitoring strategy. Cost was reported to have an impact on the choice of monitoring strategy. Self-screening was recommended by most (71%) of the respondents. The combination of absence of symptoms and recorded AF was the definition of success for most (83%) of the respondents. Cessation of anticoagulation after ablation was an option mostly for patients with paroxysmal AF and a low CHA(2)DS(2)-VASc score. The majority of physicians perform routine monitoring after AF ablation. For most physicians, the combination of the absence of symptoms and electrocardiographic endpoints defines a successful result after AF ablation. Oxford University Press 2022-11-14 /pmc/articles/PMC9934999/ /pubmed/36372986 http://dx.doi.org/10.1093/europace/euac194 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle EHRA Survey
Schwab, Ana Carolina
Anic, Ante
Farkowski, Michal M
Guerra, Jose
Iliodromitis, Konstantinos E
Jubele, Kristine
Providencia, Rui
Chun, Julian K R
Boveda, Serge
Rhythm monitoring, success definition, recurrence, and anticoagulation after atrial fibrillation ablation: results from an EHRA survey
title Rhythm monitoring, success definition, recurrence, and anticoagulation after atrial fibrillation ablation: results from an EHRA survey
title_full Rhythm monitoring, success definition, recurrence, and anticoagulation after atrial fibrillation ablation: results from an EHRA survey
title_fullStr Rhythm monitoring, success definition, recurrence, and anticoagulation after atrial fibrillation ablation: results from an EHRA survey
title_full_unstemmed Rhythm monitoring, success definition, recurrence, and anticoagulation after atrial fibrillation ablation: results from an EHRA survey
title_short Rhythm monitoring, success definition, recurrence, and anticoagulation after atrial fibrillation ablation: results from an EHRA survey
title_sort rhythm monitoring, success definition, recurrence, and anticoagulation after atrial fibrillation ablation: results from an ehra survey
topic EHRA Survey
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934999/
https://www.ncbi.nlm.nih.gov/pubmed/36372986
http://dx.doi.org/10.1093/europace/euac194
work_keys_str_mv AT schwabanacarolina rhythmmonitoringsuccessdefinitionrecurrenceandanticoagulationafteratrialfibrillationablationresultsfromanehrasurvey
AT anicante rhythmmonitoringsuccessdefinitionrecurrenceandanticoagulationafteratrialfibrillationablationresultsfromanehrasurvey
AT farkowskimichalm rhythmmonitoringsuccessdefinitionrecurrenceandanticoagulationafteratrialfibrillationablationresultsfromanehrasurvey
AT guerrajose rhythmmonitoringsuccessdefinitionrecurrenceandanticoagulationafteratrialfibrillationablationresultsfromanehrasurvey
AT iliodromitiskonstantinose rhythmmonitoringsuccessdefinitionrecurrenceandanticoagulationafteratrialfibrillationablationresultsfromanehrasurvey
AT jubelekristine rhythmmonitoringsuccessdefinitionrecurrenceandanticoagulationafteratrialfibrillationablationresultsfromanehrasurvey
AT providenciarui rhythmmonitoringsuccessdefinitionrecurrenceandanticoagulationafteratrialfibrillationablationresultsfromanehrasurvey
AT chunjuliankr rhythmmonitoringsuccessdefinitionrecurrenceandanticoagulationafteratrialfibrillationablationresultsfromanehrasurvey
AT bovedaserge rhythmmonitoringsuccessdefinitionrecurrenceandanticoagulationafteratrialfibrillationablationresultsfromanehrasurvey